| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| RMD - ResMed Inc | HOLD | 0 @ USD 244.6 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 244.6. The average price that RMD shares were previous bought at was USD 247.319. The current market price is -1.1% lower than average price they were purchased at. The value of the holding in RMD has fallen by USD 154,594 compared to the previous valuation of ResMed Inc |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 225.15 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 225.15. The average price that IQV shares were previous bought at was USD 198.541. The current market price is 13.4% higher than average price they were purchased at. The value of the holding in IQV has increased by USD 68,220 compared to the previous valuation of IQVIA Holdings Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 577.34 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 577.34. The average price that ISRG shares were previous bought at was USD 528.041. The current market price is 9.3% higher than average price they were purchased at. The value of the holding in ISRG has fallen by USD 451,377 compared to the previous valuation of Intuitive Surgical Inc |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 205.78 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 205.78. The average price that JNJ shares were previous bought at was USD 175.926. The current market price is 17.0% higher than average price they were purchased at. The value of the holding in JNJ has fallen by USD 1,897,308 compared to the previous valuation of Johnson & Johnson |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 253.15 | USD 0 | The current share valuation price of LH based on adjusted close was USD 253.15. The average price that LH shares were previous bought at was USD 255.558. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in LH has fallen by USD 80,964 compared to the previous valuation of Laboratory Corporation of America Holdings |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 1071.64 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 1071.64. The average price that LLY shares were previous bought at was USD 874.922. The current market price is 22.5% higher than average price they were purchased at. The value of the holding in LLY has fallen by USD 1,965,452 compared to the previous valuation of Eli Lilly and Company |
| MCK - McKesson Corporation | HOLD | 0 @ USD 825.73 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 825.73. The average price that MCK shares were previous bought at was USD 717.702. The current market price is 15.1% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 463,571 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 97.47 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 97.47. The average price that MDT shares were previous bought at was USD 92.399. The current market price is 5.5% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 157,410 compared to the previous valuation of Medtronic PLC |
| MOH - MOH | HOLD | 0 @ USD 164.02 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 164.02. The average price that MOH shares were previous bought at was USD 241.944. The current market price is -32.2% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 8,936 compared to the previous valuation of MOH however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | HOLD | 0 @ USD 164.02 | USD 0 | The current share valuation price of MOH based on adjusted close was USD 164.02. The average price that MOH shares were previous bought at was USD 241.944. The current market price is -32.2% lower than average price they were purchased at. The value of the holding in MOH has increased by USD 8,936 compared to the previous valuation of LVMH Moët Hennessy - Louis Vuitton Société Européenne however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 105.04 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 105.04. The average price that MRK shares were previous bought at was USD 91.3634. The current market price is 15.0% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 406,568 compared to the previous valuation of Marks Electrical Group PLC however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 105.04 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 105.04. The average price that MRK shares were previous bought at was USD 91.3634. The current market price is 15.0% higher than average price they were purchased at. The value of the holding in MRK has increased by USD 406,568 compared to the previous valuation of Merck & Company Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| MRNA - Moderna Inc | HOLD | 0 @ USD 32.29 | USD 0 | The current share valuation price of MRNA based on adjusted close was USD 32.29. The average price that MRNA shares were previous bought at was USD 31.0543. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in MRNA has fallen by USD 457,191 compared to the previous valuation of Moderna Inc |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1414.6 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1414.6. The average price that MTD shares were previous bought at was USD 1304.94. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 23,069 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1414.6 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1414.6. The average price that MTD shares were previous bought at was USD 1304.94. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 23,069 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| PFE - Pfizer Inc | HOLD | 0 @ USD 24.88 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 24.88. The average price that PFE shares were previous bought at was USD 25.4645. The current market price is -2.3% lower than average price they were purchased at. The value of the holding in PFE has fallen by USD 959,456 compared to the previous valuation of Pfizer Inc |
| PODD - Insulet Corporation | HOLD | 0 @ USD 285.5 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 285.5. The average price that PODD shares were previous bought at was USD 291.963. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in PODD has fallen by USD 216,553 compared to the previous valuation of Insulet Corporation |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 785.17 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 785.17. The average price that REGN shares were previous bought at was USD 674.504. The current market price is 16.4% higher than average price they were purchased at. The value of the holding in REGN has increased by USD 299,303 compared to the previous valuation of Regeneron Pharmaceuticals Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| INCY - Incyte Corporation | HOLD | 0 @ USD 100.91 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 100.91. The average price that INCY shares were previous bought at was USD 80.7889. The current market price is 24.9% higher than average price they were purchased at. The value of the holding in INCY has increased by USD 16,786 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| RVTY - Revvity Inc. | HOLD | 0 @ USD 97.58 | USD 0 | The current share valuation price of RVTY based on adjusted close was USD 97.58. The average price that RVTY shares were previous bought at was USD 104.507. The current market price is -6.6% lower than average price they were purchased at. The value of the holding in RVTY has fallen by USD 10,903 compared to the previous valuation of Revvity Inc. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 80.55 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 80.55. The average price that SOLV shares were previous bought at was USD 75.1094. The current market price is 7.2% higher than average price they were purchased at. The value of the holding in SOLV has fallen by USD 17,159 compared to the previous valuation of Solventum Corp. |
| STE - STERIS plc | HOLD | 0 @ USD 255.39 | USD 0 | The current share valuation price of STE based on adjusted close was USD 255.39. The average price that STE shares were previous bought at was USD 237.199. The current market price is 7.7% higher than average price they were purchased at. The value of the holding in STE has increased by USD 13,147 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 354.82 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 354.82. The average price that SYK shares were previous bought at was USD 372.476. The current market price is -4.7% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 299,202 compared to the previous valuation of Stryker Corporation |
| TECH - Bio-Techne Corp | HOLD | 0 @ USD 59.25 | USD 0 | The current share valuation price of TECH based on adjusted close was USD 59.25. The average price that TECH shares were previous bought at was USD 61.8962. The current market price is -4.3% lower than average price they were purchased at. The value of the holding in TECH has increased by USD 23,006 compared to the previous valuation of Bio-Techne Corp however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| TMO - Time Out Group plc | HOLD | 0 @ USD 579.94 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 579.94. The average price that TMO shares were previous bought at was USD 529.279. The current market price is 9.6% higher than average price they were purchased at. The value of the holding in TMO has increased by USD 814,283 compared to the previous valuation of Time Out Group plc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| UHS - Universal Health Services Inc | HOLD | 0 @ USD 227.27 | USD 0 | The current share valuation price of UHS based on adjusted close was USD 227.27. The average price that UHS shares were previous bought at was USD 200.957. The current market price is 13.1% higher than average price they were purchased at. The value of the holding in UHS has increased by USD 17,654 compared to the previous valuation of Universal Health Services Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 324.8 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 324.8. The average price that UNH shares were previous bought at was USD 419.497. The current market price is -22.6% lower than average price they were purchased at. The value of the holding in UNH has fallen by USD 166,756 compared to the previous valuation of UnitedHealth Group Incorporated |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 459.21 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 459.21. The average price that VRTX shares were previous bought at was USD 447.821. The current market price is 2.5% higher than average price they were purchased at. The value of the holding in VRTX has fallen by USD 142,716 compared to the previous valuation of Vertex Pharmaceuticals Inc |
| VTRS - Viatris Inc | HOLD | 0 @ USD 12.02 | USD 0 | The current share valuation price of VTRS based on adjusted close was USD 12.02. The average price that VTRS shares were previous bought at was USD 10.4317. The current market price is 15.2% higher than average price they were purchased at. The value of the holding in VTRS has increased by USD 5,865 compared to the previous valuation of Viatris Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| WAT - Waters Corporation | HOLD | 0 @ USD 383.21 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 383.21. The average price that WAT shares were previous bought at was USD 363.328. The current market price is 5.5% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 28,055 compared to the previous valuation of Waters Corporation |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 383.21 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 383.21. The average price that WAT shares were previous bought at was USD 363.328. The current market price is 5.5% higher than average price they were purchased at. The value of the holding in WAT has fallen by USD 28,055 compared to the previous valuation of MULETFWATIMETFP |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 277.49 | USD 0 | The current share valuation price of WST based on adjusted close was USD 277.49. The average price that WST shares were previous bought at was USD 263.355. The current market price is 5.4% higher than average price they were purchased at. The value of the holding in WST has increased by USD 96,595 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 89.43 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 89.43. The average price that ZBH shares were previous bought at was USD 100.713. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 37,366 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 123.54 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 123.54. The average price that ZTS shares were previous bought at was USD 150.132. The current market price is -17.7% lower than average price they were purchased at. The value of the holding in ZTS has fallen by USD 54,291 compared to the previous valuation of Zoetis Inc |
| CRL - Creightons Plc | HOLD | 0 @ USD 202.87 | USD 0 | The current share valuation price of CRL based on adjusted close was USD 202.87. The average price that CRL shares were previous bought at was USD 171.438. The current market price is 18.3% higher than average price they were purchased at. The value of the holding in CRL has fallen by USD 3,734 compared to the previous valuation of Creightons Plc |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 228.79 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 228.79. The average price that ABBV shares were previous bought at was USD 207.686. The current market price is 10.2% higher than average price they were purchased at. The value of the holding in ABBV has increased by USD 795,319 compared to the previous valuation of AbbVie Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 124.54 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 124.54. The average price that ABT shares were previous bought at was USD 128.185. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 586,866 compared to the previous valuation of Abbott Laboratories |
| ALGN - Align Technology Inc | HOLD | 0 @ USD 156.76 | USD 0 | The current share valuation price of ALGN based on adjusted close was USD 156.76. The average price that ALGN shares were previous bought at was USD 170.277. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in ALGN has fallen by USD 86,960 compared to the previous valuation of Align Technology Inc |
| AMGN - Amgen Inc | HOLD | 0 @ USD 331.49 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 331.49. The average price that AMGN shares were previous bought at was USD 306.115. The current market price is 8.3% higher than average price they were purchased at. The value of the holding in AMGN has increased by USD 27,536 compared to the previous valuation of Amgen Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 18.93 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 18.93. The average price that BAX shares were previous bought at was USD 27.2609. The current market price is -30.6% lower than average price they were purchased at. The value of the holding in BAX has fallen by USD 13,080 compared to the previous valuation of Baxter International Inc |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 195.67 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 195.67. The average price that BDX shares were previous bought at was USD 206.371. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in BDX has fallen by USD 157,038 compared to the previous valuation of Becton Dickinson and Company |
| BIIB - Biogen Inc | HOLD | 0 @ USD 174.82 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 174.82. The average price that BIIB shares were previous bought at was USD 150.311. The current market price is 16.3% higher than average price they were purchased at. The value of the holding in BIIB has increased by USD 8,945 compared to the previous valuation of Biogen Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 54.28 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 54.28. The average price that BMY shares were previous bought at was USD 52.3497. The current market price is 3.7% higher than average price they were purchased at. The value of the holding in BMY has fallen by USD 395,580 compared to the previous valuation of Bloomsbury Publishing Plc |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 96.09 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 96.09. The average price that BSX shares were previous bought at was USD 98.5067. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 257,742 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 96.09 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 96.09. The average price that BSX shares were previous bought at was USD 98.5067. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 257,742 compared to the previous valuation of MULSTRXSSXIMETFP |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 207.37 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 207.37. The average price that CAH shares were previous bought at was USD 155.631. The current market price is 33.2% higher than average price they were purchased at. The value of the holding in CAH has increased by USD 262,130 compared to the previous valuation of Cardinal Health Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| CI - Cigna Corp | HOLD | 0 @ USD 273.75 | USD 0 | The current share valuation price of CI based on adjusted close was USD 273.75. The average price that CI shares were previous bought at was USD 297.651. The current market price is -8.0% lower than average price they were purchased at. The value of the holding in CI has fallen by USD 253,165 compared to the previous valuation of Cigna Corp |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 39.6 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 39.6. The average price that CNC shares were previous bought at was USD 49.3984. The current market price is -19.8% lower than average price they were purchased at. The value of the holding in CNC has fallen by USD 83,106 compared to the previous valuation of Concurrent Technologies Plc |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 82.88 | USD 0 | The current share valuation price of COO based on adjusted close was USD 82.88. The average price that COO shares were previous bought at was USD 81.8261. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in COO has fallen by USD 97,449 compared to the previous valuation of The Cooper Companies, Inc. Common Stock |
| COR - Cencora Inc. | HOLD | 0 @ USD 340.59 | USD 0 | The current share valuation price of COR based on adjusted close was USD 340.59. The average price that COR shares were previous bought at was USD 303.769. The current market price is 12.1% higher than average price they were purchased at. The value of the holding in COR has increased by USD 55,585 compared to the previous valuation of Cencora Inc. however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 138.36 | USD 0 | The current share valuation price of A based on adjusted close was USD 138.36. The average price that A shares were previous bought at was USD 134.042. The current market price is 3.2% higher than average price they were purchased at. The value of the holding in A has fallen by USD 23,141 compared to the previous valuation of Agilent Technologies Inc |
| CVS - CVS Health Corp | HOLD | 0 @ USD 78.04 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 78.04. The average price that CVS shares were previous bought at was USD 70.4652. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 207,723 compared to the previous valuation of CVS Health Corp |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 175.08 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 175.08. The average price that DGX shares were previous bought at was USD 174.896. The current market price is 0.1% higher than average price they were purchased at. The value of the holding in DGX has fallen by USD 72,454 compared to the previous valuation of Quest Diagnostics Incorporated |
| DHR - Danaher Corporation | HOLD | 0 @ USD 230.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 230.83. The average price that DHR shares were previous bought at was USD 216.09. The current market price is 6.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 906,537 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 230.83 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 230.83. The average price that DHR shares were previous bought at was USD 216.09. The current market price is 6.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 906,537 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | HOLD | 0 @ USD 114.72 | USD 0 | The current share valuation price of DVA based on adjusted close was USD 114.72. The average price that DVA shares were previous bought at was USD 140.598. The current market price is -18.4% lower than average price they were purchased at. The value of the holding in DVA has fallen by USD 32,582 compared to the previous valuation of DaVita HealthCare Partners Inc |
| DXCM - DexCom Inc | HOLD | 0 @ USD 66.86 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 66.86. The average price that DXCM shares were previous bought at was USD 72.4688. The current market price is -7.7% lower than average price they were purchased at. The value of the holding in DXCM has fallen by USD 113,845 compared to the previous valuation of DexCom Inc |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 343.22 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 343.22. The average price that ELV shares were previous bought at was USD 373.442. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in ELV has fallen by USD 119,328 compared to the previous valuation of Elevance Health Inc |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 343.22 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 343.22. The average price that ELV shares were previous bought at was USD 373.442. The current market price is -8.1% lower than average price they were purchased at. The value of the holding in ELV has fallen by USD 119,328 compared to the previous valuation of Elevance Health Inc |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 86.23 | USD 0 | The current share valuation price of EW based on adjusted close was USD 86.23. The average price that EW shares were previous bought at was USD 75.5977. The current market price is 14.1% higher than average price they were purchased at. The value of the holding in EW has fallen by USD 88,958 compared to the previous valuation of Edwards Lifesciences Corp |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 83.32 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 83.32. The average price that GEHC shares were previous bought at was USD 80.4606. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in GEHC has fallen by USD 143,784 compared to the previous valuation of GE HealthCare Technologies Inc. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 125.19 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 125.19. The average price that GILD shares were previous bought at was USD 110.941. The current market price is 12.8% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 653,468 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 474.04 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 474.04. The average price that HCA shares were previous bought at was USD 393.99. The current market price is 20.3% higher than average price they were purchased at. The value of the holding in HCA has increased by USD 164,181 compared to the previous valuation of HCA Holdings Inc however if the holding was sold on 2025-12-23 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.87 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.87. The average price that HOLX shares were previous bought at was USD 69.1066. The current market price is 8.3% higher than average price they were purchased at. The value of the holding in HOLX has fallen by USD 4,511 compared to the previous valuation of Hologic Inc |
| HSIC - Henry Schein Inc | HOLD | 0 @ USD 76.5 | USD 0 | The current share valuation price of HSIC based on adjusted close was USD 76.5. The average price that HSIC shares were previous bought at was USD 71.953. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in HSIC has fallen by USD 56,688 compared to the previous valuation of Henry Schein Inc |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 257.12 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 257.12. The average price that HUM shares were previous bought at was USD 263.669. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 34,218 compared to the previous valuation of Hummingbird Resources PLC |
| HUM - Humana Inc | HOLD | 0 @ USD 257.12 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 257.12. The average price that HUM shares were previous bought at was USD 263.669. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in HUM has fallen by USD 34,218 compared to the previous valuation of Humana Inc |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 682.31 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 682.31. The average price that IDXX shares were previous bought at was USD 562.443. The current market price is 21.3% higher than average price they were purchased at. The value of the holding in IDXX has fallen by USD 810,348 compared to the previous valuation of IDEXX Laboratories Inc |